儿童肾盂成形术后尿路感染:引流管类型、手术方式与预防性抗生素的多中心分析
该多中心回顾性研究纳入435例接受肾盂成形术的儿童患者,术后尿路感染(UTI)发生率为18.4%。引流管类型是感染的最强预测因素,双J管(DJS)单独组感染率14.8%,外支架组26.6%,DJS+肾造瘘管组35.1%。出院时预防性抗生素与感染无关联(OR 0.96,P=.781),不支持常规使用。
要点
- 引流管类型是儿童肾盂成形术后UTI的最强预测因素,外化引流配置风险更高。
- 出院预防性抗生素未降低UTI风险,且在任一引流亚组中均无获益。
- 肾盂减容术独立降低UTI风险(OR 0.52,95%CI 0.30-0.88,P=.015)。
核心结论
- 引流管配置而非抗生素预防是儿童肾盂成形术后感染风险的主要决定因素。
- 常规出院后预防性抗生素无显著获益,对内支架患者可考虑不予使用。
研究设计与样本
- 回顾性多中心队列研究,纳入2个儿童泌尿中心连续435例肾盂成形术患者。
- 术后UTI定义为培养证实的感染伴发热或泌尿症状,排除无症状菌尿。
主要发现
- UTI总发生率为18.4%(80/435)。
- 双J管(DJS)单独组UTI率14.8%,Pippi Salle外支架组26.6%,DJS+肾造瘘管(PCN)联合组35.1%(P=.003)。
- 外化引流配置为独立危险因素:OR 1.77(95%CI 1.18-2.68,P=.006)和OR 1.63(95%CI 1.21-2.21,P=.001)。
- 肾盂减容术独立保护(OR 0.52,95%CI 0.30-0.88,P=.015)。
- 开放手术单因素显著(25.5% vs 15.0%,P=.011),校正后不显著(OR 1.34,P=.302)。
临床怎么用
- 儿童肾盂成形术后应依据引流管类型进行风险分层,外化引流配置患者可能需更密切监测。
- 对内支架患者,常规出院预防性抗生素可合理省略。
局限性
- 回顾性设计可能存在选择偏倚和未测量混杂。
- 预防性抗生素使用非随机,各引流亚组样本量可能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether antibiotic prophylaxis at discharge reduces post-operative urinary tract infection (UTI) after pediatric pyeloplasty, and to identify independent predictors of infection. METHODS: We retrospectively reviewed 435 consecutive patients who underwent pyeloplasty at 2 pediatric urology centers. Post-operative UTI was defined as a culture-proven infection accompanied by fever or urinary symptoms; asymptomatic bacteriuria was excluded. Univariate comparisons used chi-square, Fisher's exact and Mann-Whitney U tests. A multivariable logistic regression model with Wald-based confidence intervals identified independent predictors; collinearity was assessed by variance inflation factors and confirmed by sensitivity, interaction and surgical-era analyses. RESULTS: UTI occurred in 80 patients (18.4%). Drain type was the strongest predictor (P=.003): 14.8% with double-J stent (DJS) alone, 26.6% with Pippi Salle external stent and 35.1% with combined DJS+PCN. Both externalized configurations remained independent risk factors after adjustment (OR 1.77, 95% CI 1.18-2.68, P=.006; OR 1.63, 95% CI 1.21-2.21, P=.001). Pelvic reduction was independently protective (OR 0.52, 95% CI 0.30-0.88, P=.015). Open surgery was significant on univariate analysis (25.5% vs 15.0%, P=.011) but not after adjustment (OR 1.34, P=.302). Prophylaxis, prescribed in 168 patients (38.6%), showed no association with infection (OR 0.96, P=.781) and no benefit within any drainage subgroup. Drain duration was not associated with infection. CONCLUSION: Drainage configuration, not antibiotic prophylaxis, is the principal determinant of infection risk after pediatric pyeloplasty. Routine post-discharge prophylaxis confers no measurable benefit and may reasonably be withheld in patients managed with an internal stent, supporting a risk-stratified approach guided by drain selection.
引用
- Neeman BB, Chertin B, Rubin P, et al. Post-operative Urinary Tract Infection After Pediatric Pyeloplasty: A Multicenter Analysis of Drain Type, Surgical Approach, and Prophylactic Antibiotics. Urology. 2026. PMID: 42607895. doi:10.1016/j.urology.2026.08.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。